Cargando…
Blocking LINGO-1 in vivo reduces degeneration and enhances regeneration of the optic nerve
BACKGROUND: Two ongoing phase II clinical trials (RENEW and SYNERGY) have been developed to test the efficacy of anti-LINGO-1 antibodies in acute optic neuritis and relapsing forms of multiple sclerosis, respectively. Across a range of experimental models, LINGO-1 has been found to inhibit neuron an...
Autores principales: | Gresle, Melissa M, Liu, Yaou, Kilpatrick, Trevor J, Kemper, Dennis, Wu, Qi-Zhu, Hu, Bing, Fu, Qing-Ling, So, Kwok-Fai, Sheng, Guoqing, Huang, Guanrong, Pepinsky, Blake, Butzkueven, Helmut, Mi, Sha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433342/ https://www.ncbi.nlm.nih.gov/pubmed/28607723 http://dx.doi.org/10.1177/2055217316641704 |
Ejemplares similares
-
Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding site
por: Hanf, Karl J. M., et al.
Publicado: (2020) -
Programación en Lingo /
por: Pescador Albiach, Darío
Publicado: (1997) -
Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis
por: Jokubaitis, Vilija G, et al.
Publicado: (2013) -
Lingo dictionary : Director, version 4.
Publicado: (1994) -
Using lingo : Director, version 4.
Publicado: (1994)